Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Metastasis02:30

Metastasis

5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Cancer Therapies02:49

Cancer Therapies

8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC.

Nature·2026
Same author

The role of ATP synthase subunit e (ATP5I) in mediating the metabolic and antiproliferative effects of metformin in cancer cells.

eLife·2026
Same author

STAT1/3/5 Functions Driving Lipid and Energy Metabolism in Cancer and Immunity.

International journal of molecular sciences·2026
Same author

Targeting the Lipid Metabolism Proteins FASN and GPAM in Alveolar Type II Cells Decreases Lung Metastasis.

Cancer discovery·2026
Same author

Precision targeting of the SASP in cancer therapy.

Nature aging·2026
Same author

Increased chromatin accessibility underpins senescence.

The FEBS journal·2025

Related Experiment Video

Updated: Sep 27, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

685

Liquid-Liquid Phase Separation in Cancer Signaling, Metabolism and Anticancer Therapy.

Sebastian Igelmann1,2, Frédéric Lessard3, Gerardo Ferbeyre1,2

  • 1Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC H3C 3J7, Canada.

Cancers
|April 12, 2022
PubMed
Summary

Cancer cell states can be maintained by structural changes forming biological condensates. These condensates, driven by specific proteins and RNAs, regulate cancer gene expression and metabolism, offering potential drug targets.

Keywords:
biomolecular condensatesliquid-liquid phase separationmetabolon

More Related Videos

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.0K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.6K

Related Experiment Videos

Last Updated: Sep 27, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

685
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.0K
Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.6K

Area of Science:

  • Cellular Biology
  • Cancer Research
  • Biophysics

Background:

  • Cancer progression is traditionally linked to genetic and epigenetic alterations driving aberrant gene expression.
  • Emerging evidence highlights the role of cellular structural reorganization in maintaining stable cellular states.
  • Liquid-liquid phase separation (LLPS) is a key biophysical process driving the formation of biological condensates.

Purpose of the Study:

  • To review the role of cancer-specific biological condensates in maintaining the cancer state.
  • To explore the molecular drivers and regulatory functions of these condensates in cancer.
  • To discuss the therapeutic potential of targeting oncogenic biological condensates (OBCs).

Main Methods:

  • Literature review of studies investigating biological condensates in cancer.
  • Analysis of data linking mutant oncoproteins, RNA-binding proteins, and lincRNAs to condensate formation.
  • Examination of condensate roles in regulating oncogenic gene expression and cancer metabolism.

Main Results:

  • Cancer-specific biological condensates are formed and maintained through LLPS.
  • These condensates are initiated by oncogenic drivers such as mutant oncoproteins, RNA-binding proteins, and long non-coding RNAs (lincRNAs).
  • Oncogenic biological condensates actively regulate cancer-promoting gene expression programs and metabolic pathways.

Conclusions:

  • Biological condensates represent a novel mechanism for stably maintaining cancer cell states.
  • Targeting these oncogenic biological condensates (OBCs) is a promising strategy for cancer therapy.
  • Anticancer drugs may be designed to specifically partition into OBCs, enhancing therapeutic efficacy.